Aktis Oncology, Inc. (AKTS)

Aktis Oncology Revenue

Aktis Oncology had revenue of $3.23M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $8.28M, up 1,394.04% year-over-year. In the year 2025, Aktis Oncology had annual revenue of $6.50M with 336.92% growth.

• Revenue (ttm): $8.28M
• Revenue Growth: +1,394.04%
• P/S Ratio: 196.61
• Revenue / Employee: $104,772
• Employees: 79
• Market Cap: 1.63B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.50M	5.01M	336.92%
Dec 31, 2024	1.49M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: May 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 23, 2026

Data Sources Report a data error